BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Sigma-Tau Pharmaceuticals 

800 South Frederick Avenue, Suite 300

Gaithersburg  Maryland  20877  U.S.A.
Phone: 800-447-0169 Fax:


SEARCH JOBS




Industry
Pharmaceutical


Collaborations

HEMOSYSTEM® SA  exclusive worldwide license for L-carnitine patents related to the blood transfusion field

SciClone Pharmaceuticals, Inc.  European Union partner for the development and commercialization of ZADAXIN in Europe.





 Company News
Jazz Pharmaceuticals plc (JAZZ) Wagers Up To $250 Million On Rare Disease Drug From Sigma-Tau Pharmaceuticals 7/2/2014 6:45:51 AM
Sigma-Tau Pharmaceuticals Announces First Patient Dosed In Phase 1/2 Clinical Trial Of STP206 For Prevention Of Necrotizing Enterocolitis In Very Low Birth Weight Premature Infants 2/4/2014 9:14:00 AM
Sigma-Tau PharmaSource, Inc. and Aradigm Corporation (ARDM) Sign Manufacturing Agreement for the Clinical and Commercial Supply of Pulmaquin 9/16/2013 10:00:36 AM
Sigma-Tau Pharmaceuticals Receives Innovation Award From the National Organization for Rare Disorders for Its Advancements in Rare Diseases 5/16/2013 9:12:27 AM
Sigma-Tau Pharmaceuticals Launches CYSTARAN™ for the Treatment of Corneal Cystine Crystal Accumulation in Patients With Cystinosis 5/1/2013 11:44:49 AM
Dave Lemus Promoted to CEO of Sigma-Tau Pharmaceuticals 4/29/2013 8:52:57 AM
Sigma-Tau Pharmaceuticals Announces Appointment of New Vice President of Commercial Operations 10/29/2012 7:10:42 AM
Sigma-Tau Pharmaceuticals Announces the U.S. Launch of VSL#3® JUNIOR 10/16/2012 9:40:06 AM
Sigma-Tau Pharmaceuticals Offers New Co-Pay Assistance Program for Adagen® Patients 10/9/2012 9:12:49 AM
Sigma-Tau Pharmaceuticals Receives FDA Approval of CYSTARAN™ 10/4/2012 7:16:29 AM
12345